[ad_1]
By Nate Raymond
July 5 (Reuters) – A US judge on Thursday overturned a $ 140.1 million verdict against AbbVie Inc. in a lawsuit by a man who claimed the company misrepresented the of AndroGel testosterone replacement drug, the cause to suffer a heart attack.
US Judge Matthew Kennelly in Chicago ordered a retrial in the lawsuit brought by Tennessee resident Jeffrey Konrad, whose case is one of the abovementioned faces in Andromagel.
In October, awarded jurors Konrad $ 140,000 in compensatory damages and $ 140 million Injury and mischief in the face of AndroGel (19659002) But Kennelly said the jury was finding fault with the claim.
"When this happens, the court can not accept one of the two inconsistent verdicts while" Kennelly wrote.
] AbbVie did not immediately respond to a request for comment. A lawyer for Konrad also said:
Chicago-based AbbVie has said it faces 4,500 boxes nationally in which plaintiffs claim the company did not adequately warn about risks of heart attacks, strokes and blood clots that could (19659002) The verdict in Konrad's lawsuit came into force in the United States of America.
Konrad had he had been using AndroGel for two months in 2010 when he suffered a heart attack. He has gotten back from his injuries
Thursday's ruling marked the second time Kennelly has ordered a retrial in one of the test, or bellwether, boxes.
In December, he overturned a verdict in which awarded jurors $ 150 million in Jesse Mitchell, who said he suffered a heart attack after using AndroGel
Mitchell's case was retried, and jurors in March ordered $ 3.2 million.
The lawsuits by Konrad and Mitchell are among those who have gone to AndroGel. The case is in Re: Testosterone Replacement Therapy Products Liability Litigation, U.S. District Court, Northern District of Illinois, No. 14-cv-01748. (Reporting by Raymond Nate in Boston, edited by Jonathan Oatis and David Gregorio)
Our Standards: The Thomson Reuters Trust Principles.
Source link
